{
    "organizations": [],
    "uuid": "9a9a8d3865abde713fda2fc825965df8d613603e",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-therapix-biosciences-co-terminated/brief-therapix-biosciences-co-terminated-research-license-agreement-between-co-yissum-research-development-co-idUSFWN1RX0DM",
    "ord_in_thread": 0,
    "title": "BRIEF-Therapix Biosciences - Co Terminated Research & License Agreement Between Co, Yissum Research Development Co",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 20 (Reuters) - Therapix Biosciences Ltd:\n* THERAPIX BIOSCIENCES - ON MARCH 18, 2018 CO TERMINATED RESEARCH & LICENSE AGREEMENT BETWEEN CO, YISSUM RESEARCH DEVELOPMENT CO, DATED MARCH 30, 2017 Source text: ( bit.ly/2F372wh ) Further company coverage: (Reuters.Briefs@thomsonreuters.com)\n ",
    "published": "2018-04-20T19:38:00.000+03:00",
    "crawled": "2018-04-21T18:05:46.001+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "therapix",
        "bioscience",
        "ltd",
        "therapix",
        "bioscience",
        "march",
        "co",
        "terminated",
        "research",
        "license",
        "agreement",
        "co",
        "yissum",
        "research",
        "development",
        "co",
        "dated",
        "march",
        "source",
        "text",
        "company",
        "coverage"
    ]
}